• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comput Struct Biotechnol J . Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins

tetano

Editor, Senior Moderator
Comput Struct Biotechnol J


. 2024 May 24:23:2407-2417.
doi: 10.1016/j.csbj.2024.05.037. eCollection 2024 Dec. Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins

Muhammad Hasan[SUP] 1 2 [/SUP], Zhouyi He[SUP] 1 2 [/SUP], Mengqi Jia[SUP] 1 [/SUP], Alvin C F Leung[SUP] 1 3 [/SUP], Kathiresan Natarajan[SUP] 4 [/SUP], Wentao Xu[SUP] 1 [/SUP], Shanqi Yap[SUP] 1 [/SUP], Feng Zhou[SUP] 1 [/SUP], Shihong Chen[SUP] 1 [/SUP], Hailei Su[SUP] 5 [/SUP], Kaicheng Zhu[SUP] 1 [/SUP], Haibin Su[SUP] 1 2 [/SUP]



Affiliations
Abstract

The continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused the recent pandemic, has generated countless new variants with varying fitness. Mutations of the spike glycoprotein play a particularly vital role in shaping its evolutionary trajectory, as they have the capability to alter its infectivity and antigenicity. We present a time-resolved statistical method, Dynamic Expedition of Leading Mutations (deLemus), to analyze the evolutionary dynamics of the SARS-CoV-2 spike glycoprotein. The proposed L -index of the deLemus method is effective in quantifying the mutation strength of each amino acid site and outlining evolutionarily significant sites, allowing the comprehensive characterization of the evolutionary mutation pattern of the spike glycoprotein.


 
Back
Top Bottom